{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:06:28Z","timestamp":1761393988938},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2334-10-347","type":"journal-article","created":{"date-parts":[[2010,12,9]],"date-time":"2010-12-09T19:14:23Z","timestamp":1291922063000},"source":"Crossref","is-referenced-by-count":6,"title":["Immunity status of adults and children against poliomyelitis virus type 1 strains CHAT and Sabin (LSc-2ab) in Germany"],"prefix":"10.1186","volume":"10","author":[{"given":"Maren","family":"Eggers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Terletskaia-Ladwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger F","family":"Rabenau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans W","family":"Doerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Diedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisela","family":"Enders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Enders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,9]]},"reference":[{"key":"1327_CR1","unstructured":"EN 14476:2007-02: Chemical disinfectants and antiseptics - Virucidal quantitative suspensiontest for chemical disinfectants and antiseptics used in human medicine - Test method and requirements (phase 2\/step 1). 2007"},{"key":"1327_CR2","volume-title":"Scientific publication no. 44. Pan American Sanitary Bureau. Washington. D.C","author":"VJ Cabasso","year":"1959","unstructured":"Cabasso VJ, Jervis G, Moyer AW, Roca-Garcia M, Orsi EV, Cox HR: Cumulative testing experience with consecutive lots of oral poliomyelitis vaccine. p. 102-134. In Live poliovirus vaccines. First International Conference on Live Poliovirus Vaccines. Scientific publication no. 44. Pan American Sanitary Bureau. Washington. D.C. 1959"},{"key":"1327_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0092-1157(73)90048-6","volume":"1","author":"AB Sabin","year":"1973","unstructured":"Sabin AB, Boulger LR: History of Sabin attenuated poliovirus oral live vaccines. J Biol Stand. 1973, 1: 115-118. 10.1016\/0092-1157(73)90048-6.","journal-title":"J Biol Stand"},{"issue":"11","key":"1327_CR4","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.1128\/JVI.76.11.5339-5349.2002","volume":"76","author":"J Mart\u00edn","year":"2002","unstructured":"Mart\u00edn J, Minor PD: Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains. J Virol. 2002, 76 (11): 5339-49.","journal-title":"J Virol"},{"key":"1327_CR5","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2105\/AJPH.50.7.1013","volume":"50","author":"JL Melnick","year":"1960","unstructured":"Melnick JL: Problems associated with the use of live poliovirus vaccine. Am J Public Health Nations Health. 1960, 50: 1013-31. 10.2105\/AJPH.50.7.1013.","journal-title":"Am J Public Health Nations Health"},{"issue":"4","key":"1327_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1086\/321905","volume":"33","author":"VM C\u00e1ceres","year":"2001","unstructured":"C\u00e1ceres VM, Sutter RW: Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. Clin Infect Dis. 2001, 33 (4): 531-41.","journal-title":"Clin Infect Dis"},{"key":"1327_CR7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1017\/S0025727300010279","volume":"50","author":"U Lidner","year":"2006","unstructured":"Lidner U, Blume SS: Vaccine innovation and adoption: Polio vaccines in the UK. the Netherlands and West Germany. 1955-1965. Medical History. 2006, 50: 425-446.","journal-title":"Medical History"},{"issue":"19","key":"1327_CR8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1055\/s-2007-1024365","volume":"125","author":"S Diedrich","year":"2000","unstructured":"Diedrich S, Claus H, Thierfelder W, Schreier E: Bundesgesundheitssurvey: Immunit\u00e4tslage gegen Poliomyelitis. Dtsch Med Wschr. 2000, 125 (19): 584-588. 10.1055\/s-2007-1024365.","journal-title":"Dtsch Med Wschr"},{"issue":"34","key":"1327_CR9","first-page":"pii","volume":"8","author":"R Pebody","year":"2004","unstructured":"Pebody R: Polio vaccination in Europe: the shift from OPV to IPV use. Euro Surveill. 2004, 8 (34): pii-2529. [ http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=2529 ]","journal-title":"Euro Surveill"},{"issue":"14","key":"1327_CR10","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.292.14.1696","volume":"292","author":"LN Alexander","year":"2004","unstructured":"Alexander LN, Seward JF, Santibanez TA, Pallansch MA, Kew OM, Prevots DR, Strebel PM, Cono J, Wharton M, Orenstein WA, Sutter RW: Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA. 2004, 292 (14): 1696-701. 10.1001\/jama.292.14.1696.","journal-title":"JAMA"},{"issue":"3","key":"1327_CR11","first-page":"86","volume":"34","author":"M Eggers","year":"2009","unstructured":"Eggers M, Terletskaia-Ladwig E, Enders G, Enders M: Immunity status of laboratory workers against poliomyelitis virus type 1 strain CHAT and Sabin (LSc-2ab). Hyg Med. 2009, 34 (3): 86-89.","journal-title":"Hyg Med"},{"key":"1327_CR12","volume-title":"Geneva: World Health Organization","author":"WHO","year":"1997","unstructured":"WHO: Manual for the virological investigation of polio. Geneva: World Health Organization. 1997, (WHO\/EPI\/GEN\/97.01)"},{"key":"1327_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2334-2-2","volume":"2","author":"S Diedrich","year":"2002","unstructured":"Diedrich S, Claus H, Schreier E: Immunity status against poliomyelitis in Germany: determination of cut-off values in International Units. BMC Infect Dis. 2002, 2: 2-10.1186\/1471-2334-2-2.","journal-title":"BMC Infect Dis"},{"key":"1327_CR14","first-page":"605","volume-title":"Poliovirus vaccine--inactivated","author":"SA Plotkin","year":"2004","unstructured":"Plotkin SA, Vidor E: Poliovirus vaccine--inactivated. Edited by: Plotkin SA, Walter A. 2004, Vaccines. Saunders. Orenstein, 605-29. 4","edition":"4"},{"issue":"3","key":"1327_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1045-1056(05)80039-9","volume":"20","author":"DJ Wood","year":"1992","unstructured":"Wood DJ, Heath AB: The Second International Standard for anti-poliovirus sera types 1, 2 and 3. Biologicals. 1992, 20 (3): 203-11. 10.1016\/S1045-1056(05)80039-9.","journal-title":"Biologicals"},{"key":"1327_CR16","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1099\/vir.0.19088-0","volume":"84","author":"J Martin","year":"2003","unstructured":"Martin J, Crossland G, Wood DJ, Minor PD: Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains. J Gen Virol. 2003, 84: 1781-8. 10.1099\/vir.0.19088-0.","journal-title":"J Gen Virol"},{"issue":"1","key":"1327_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.biologicals.2004.11.001","volume":"33","author":"G Rezapkin","year":"2005","unstructured":"Rezapkin G, Martin J, Chumakov K: Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method. Biologicals. 2005, 33 (1): 29-39. 10.1016\/j.biologicals.2004.11.001. Epub 2005 Jan 27","journal-title":"Biologicals"},{"key":"1327_CR18","volume-title":"Module 6: Poliomyelitis. The Immunological Basis for Immunization Series","author":"S Robertson","year":"1993","unstructured":"Robertson S: Module 6: Poliomyelitis. The Immunological Basis for Immunization Series. 1993, Geneva, WHO, WHO\/EPI\/GEN\/93.16"},{"key":"1327_CR19","first-page":"312","volume":"70","author":"HM Gelfand","year":"1959","unstructured":"Gelfand HM, LeBLanc DR, Potash L, Fox JP: Studies on the development of natural immunity to poliomyelitis in Louisiana. IV. Natural infections with polioviruses following immunization with a formalin-inactivated vaccine. Am J Hyg. 1959, 70: 312-27.","journal-title":"Am J Hyg"},{"issue":"1","key":"1327_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0092-1157(84)80015-3","volume":"12","author":"O Nishio","year":"1984","unstructured":"Nishio O, Ishihara Y, Sakae K, Nonomura Y, Kuno A, Yasukawa S, Inoue H, Miyamura K, Kono R: The trend of acquired immunity with live poliovirus vaccine and the effect of revaccination: follow-up of vaccinees for ten years. J Biol Stand. 1984, 12 (1): 1-10. 10.1016\/S0092-1157(84)80015-3.","journal-title":"J Biol Stand"},{"issue":"2","key":"1327_CR21","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2105\/AJPH.53.2.274","volume":"53","author":"HW McKay","year":"1963","unstructured":"McKay HW, Fodor AR, Kokko UP: Viremia Following the Administration of Live Poliovirus Vaccines. Am J Public Health Nations Health. 1963, 53 (2): 274-85. 10.2105\/AJPH.53.2.274.","journal-title":"Am J Public Health Nations Health"},{"key":"1327_CR22","volume-title":"The Immunological Bass for Immunization Series. Module 56: Poliomyelitis","author":"WHO","year":"1993","unstructured":"WHO: The Immunological Bass for Immunization Series. Module 56: Poliomyelitis. 1993, Geneva: World Health Organization, (WHO\/EPI\/GEN\/93.16)"},{"issue":"6","key":"1327_CR23","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1086\/427810","volume":"191","author":"F Abbink","year":"2005","unstructured":"Abbink F, Buisman AM, Doornbos G, Woldman J, Kimman TG, Conyn-van Spaendonck MA: Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion. J Infect Dis. 2005, 191 (6): 990-9. 10.1086\/427810.","journal-title":"J Infect Dis"},{"issue":"23","key":"1327_CR24","first-page":"213","volume":"85","author":"WHO position paper","year":"2010","unstructured":"WHO position paper: Polio vaccines and polio immunization in the pre-eradication era. Wkly Epidemiol Rec. 2010, 85 (23): 213-28.","journal-title":"Wkly Epidemiol Rec"},{"issue":"4","key":"1327_CR25","first-page":"311","volume":"80","author":"WR Dowdle","year":"2002","unstructured":"Dowdle WR, Gary HE, Sanders R, van Loon AM: Can post-eradication laboratory containment of wild polioviruses be achieved?. Bull World Health Organ. 2002, 80 (4): 311-6.","journal-title":"Bull World Health Organ"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-10-347\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T23:19:36Z","timestamp":1559863176000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-10-347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1327"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-10-347","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]},"article-number":"347"}}